CTOs on the Move


 
NJMHI is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.njmhi.org
  • 3575 Quakerbridge Rd
    Trenton, NJ USA 08619
  • Phone: 609.838.5488

Executives

Name Title Contact Details

Similar Companies

Chester River Health System

Chester River Health System is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Chestertown, MD. To find more information about Chester River Health System, please visit www.chesterriverhealth.org

Renue Physical Therapy

Renue Physical Therapy was established in the Fall of 2011 with one clinic on Bay Road in Saginaw. Our goal from the start was to create a fully patient-focused practice model. We take pride in offering one-on-one treatment with the same therapy team throughout the course of therapy, providing a customized plan that is specific to your needs to help you achieve the best possible outcomes. Since our start in 2011, Renue has grown to more than 12 clinics serving the Great Lakes Bay Region and beyond, with locations in Auburn, Au Gres, Bay City, Bridgeport, Caro, Freeland, Midland, Saginaw and Shields.

Huntington Medical Research Insitutes

Huntington Medical Research Insitutes is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sunlit Gardens Assisted Living

Sunlit Gardens Assisted Living is a Rancho Cucamonga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.